Moody Lynn & Lieberson, LLC Merck & Co., Inc. Transaction History

Moody Lynn & Lieberson, LLC

  • $1.47 Billion
  • Q2 2024

A detailed history of Moody Lynn & Lieberson, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 132,972 shares of MRK stock, worth $14.4 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
132,972
Previous 118,573 12.14%
Holding current value
$14.4 Million
Previous $15.6 Million 5.22%
% of portfolio
1.12%
Previous 1.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
BUY
$123.8 - $132.96 $1.78 Million - $1.91 Million
14,399 Added 12.14%
132,972 $16.5 Million
Q1 2024

Apr 23, 2024
BUY
$113.24 - $131.95 $1.8 Million - $2.1 Million
15,928 Added 15.52%
118,573 $15.6 Million
Q4 2023

Jan 24, 2024
SELL
$100.18 - $109.02 $18,934 - $20,604
-189 Reduced 0.18%
102,645 $11.2 Million
Q3 2023

Oct 24, 2023
BUY
$102.95 - $114.33 $10,192 - $11,318
99 Added 0.1%
102,834 $10.6 Million
Q2 2023

Jul 27, 2023
SELL
$108.61 - $118.38 $1.68 Million - $1.84 Million
-15,508 Reduced 13.12%
102,735 $11.9 Million
Q1 2023

May 02, 2023
BUY
$102.94 - $114.86 $629,272 - $702,139
6,113 Added 5.45%
118,243 $12.6 Million
Q4 2022

Feb 01, 2023
BUY
$87.44 - $112.11 $1.12 Million - $1.44 Million
12,823 Added 12.91%
112,130 $12.4 Million
Q3 2022

Oct 26, 2022
SELL
$84.53 - $94.96 $221,384 - $248,700
-2,619 Reduced 2.57%
99,307 $8.55 Million
Q2 2022

Jul 28, 2022
BUY
$83.49 - $94.64 $3.18 Million - $3.6 Million
38,071 Added 59.62%
101,926 $9.29 Million
Q1 2022

Apr 27, 2022
BUY
$73.51 - $82.4 $376,812 - $422,382
5,126 Added 8.73%
63,855 $5.24 Million
Q4 2021

Jan 26, 2022
SELL
$72.28 - $90.54 $11,564 - $14,486
-160 Reduced 0.27%
58,729 $4.5 Million
Q3 2021

Oct 26, 2021
SELL
$71.68 - $78.83 $2.31 Million - $2.54 Million
-32,262 Reduced 35.39%
58,889 $4.42 Million
Q2 2021

Jul 28, 2021
BUY
$70.31 - $77.77 $837,110 - $925,929
11,906 Added 15.02%
91,151 $7.09 Million
Q1 2021

Apr 23, 2021
BUY
$68.86 - $81.11 $435,677 - $513,182
6,327 Added 8.68%
79,245 $6.11 Million
Q4 2020

Jan 26, 2021
SELL
$71.77 - $79.65 $1.61 Million - $1.79 Million
-22,480 Reduced 23.56%
72,918 $5.97 Million
Q3 2020

Oct 28, 2020
SELL
$73.18 - $82.95 $475,377 - $538,843
-6,496 Reduced 6.38%
95,398 $7.91 Million
Q2 2020

Jul 24, 2020
SELL
$70.42 - $80.13 $69,504 - $79,088
-987 Reduced 0.96%
101,894 $7.88 Million
Q1 2020

Apr 30, 2020
BUY
$63.36 - $87.82 $1.86 Million - $2.58 Million
29,432 Added 40.07%
102,881 $7.92 Million
Q4 2019

Jan 28, 2020
BUY
$77.58 - $87.54 $405,277 - $457,308
5,224 Added 7.66%
73,449 $6.68 Million
Q3 2019

Oct 28, 2019
SELL
$76.08 - $82.93 $4.55 Million - $4.96 Million
-59,824 Reduced 46.72%
68,225 $5.74 Million
Q2 2019

Jul 23, 2019
BUY
$69.84 - $81.59 $4.02 Million - $4.7 Million
57,553 Added 81.64%
128,049 $10.7 Million
Q1 2019

Apr 23, 2019
SELL
$69.58 - $79.36 $4.86 Million - $5.54 Million
-69,831 Reduced 49.76%
70,496 $5.86 Million
Q4 2018

Jan 29, 2019
BUY
$65.24 - $75.71 $724,098 - $840,305
11,099 Added 8.59%
140,327 $10.7 Million
Q3 2018

Oct 29, 2018
BUY
$57.69 - $67.84 $4.19 Million - $4.92 Million
72,580 Added 128.12%
129,228 $9.17 Million
Q2 2018

Jul 24, 2018
SELL
$50.83 - $59.72 $49,610 - $58,286
-976 Reduced 1.69%
56,648 $3.44 Million
Q1 2018

Apr 27, 2018
SELL
$50.96 - $59.23 $47,698 - $55,439
-936 Reduced 1.6%
57,624 $3.14 Million
Q4 2017

Feb 02, 2018
SELL
$51.62 - $61.64 $2.66 Million - $3.18 Million
-51,604 Reduced 46.84%
58,560 $3.55 Million
Q3 2017

Nov 06, 2017
BUY
$58.67 - $63.13 $6.46 Million - $6.95 Million
110,164
110,164 $7.05 Million

Others Institutions Holding MRK

# of Institutions
3,824
Shares Held
1.91B
Call Options Held
13.4M
Put Options Held
10.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $275B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Moody Lynn & Lieberson, LLC Portfolio

Follow Moody Lynn & Lieberson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email